Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepa Bhojwani

Showing results (61-70 of 125) with videos related to

Pageof 13
Sort By:
Pediatric Blood & Cancer|May 18, 2016
The Role of Leukapheresis in the Current Management of Hyperleukocytosis in Newly Diagnosed Childhood Acute Lymphoblastic LeukemiaRosa Nguyen, Sima Jeha, Yinmei Zhou, et al.
Cancers|September 12, 2017
The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALLEtai Adam, Hye Na Kim, Eun Ji Gang, et al.
Blood|July 11, 2006
Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group studyDeepa Bhojwani, Huining Kang, Naomi P Moskowitz, et al.
British Journal of Haematology|September 3, 2011
Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignanciesHiroto Inaba, Deepa Bhojwani, Jennifer L Pauley, et al.
British Journal of Haematology|May 2, 2023
Efficacy and safety of FLAG-IDA as front-line therapy in de novo paediatric acute myeloid leukaemia populationAndrew Doan, Holly K T Huang, Ari J Hadar, et al.
The Lancet. Haematology|September 24, 2016
Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysisYin Ting Cheung, Noah D Sabin, Wilburn E Reddick, et al.
Experimental Hematology|June 23, 2026
Integrin alpha 4 inhibition prolongs the survival of NSG mice engrafted with CD19-negative post-CART19 relapsed B-ALLHye Na Kim, Samantha Hurwitz, Tatiana Fourfouris, et al.
Pharmacogenomics|August 2, 2014
Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypesJ Kevin Hicks, Kristine R Crews, Patricia Flynn, et al.
Pediatric Blood & Cancer|September 22, 2020
Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reductionNirali N Shah, Jennifer Schneiderman, Denison Kuruvilla, et al.
Blood|November 10, 2021
Germline GATA1s-generating mutations predispose to leukemia with acquired trisomy 21 and Down syndrome-like phenotypeHenrik Hasle, Ronald M Kline, Eigil Kjeldsen, et al.
Pageof 13

Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
Pediatric Blood & Cancer|May 18, 2016
The Role of Leukapheresis in the Current Management of Hyperleukocytosis in Newly Diagnosed Childhood Acute Lymphoblastic LeukemiaRosa Nguyen, Sima Jeha, Yinmei Zhou, et al.
Cancers|September 12, 2017
The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALLEtai Adam, Hye Na Kim, Eun Ji Gang, et al.
Blood|July 11, 2006
Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group studyDeepa Bhojwani, Huining Kang, Naomi P Moskowitz, et al.
British Journal of Haematology|September 3, 2011
Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignanciesHiroto Inaba, Deepa Bhojwani, Jennifer L Pauley, et al.
British Journal of Haematology|May 2, 2023
Efficacy and safety of FLAG-IDA as front-line therapy in de novo paediatric acute myeloid leukaemia populationAndrew Doan, Holly K T Huang, Ari J Hadar, et al.
The Lancet. Haematology|September 24, 2016
Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysisYin Ting Cheung, Noah D Sabin, Wilburn E Reddick, et al.
Experimental Hematology|June 23, 2026
Integrin alpha 4 inhibition prolongs the survival of NSG mice engrafted with CD19-negative post-CART19 relapsed B-ALLHye Na Kim, Samantha Hurwitz, Tatiana Fourfouris, et al.
Pharmacogenomics|August 2, 2014
Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypesJ Kevin Hicks, Kristine R Crews, Patricia Flynn, et al.
Pediatric Blood & Cancer|September 22, 2020
Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reductionNirali N Shah, Jennifer Schneiderman, Denison Kuruvilla, et al.
Blood|November 10, 2021
Germline GATA1s-generating mutations predispose to leukemia with acquired trisomy 21 and Down syndrome-like phenotypeHenrik Hasle, Ronald M Kline, Eigil Kjeldsen, et al.
Pageof 13